Multifunctional nanoplatforms for subcellular delivery of drugs in cancer therapy
To achieve highly effective treatment to diseases, successful delivery of drugs with a carrier into the specific organelles (nucleus, mitochondria, lysosomes, etc.) is of great importance. Targeted delivery based on nanoparticle (NP)-based drug delivery systems (NDDSs) is mainly focused on cell-memb...
Ausführliche Beschreibung
Autor*in: |
Guo, Xing [verfasserIn] |
---|
Format: |
E-Artikel |
---|---|
Sprache: |
Englisch |
Erschienen: |
2020transfer abstract |
---|
Schlagwörter: |
---|
Übergeordnetes Werk: |
Enthalten in: Assessing the potential of solid dispersions to improve dissolution rate and bioavailability of valsartan: - Medarević, Djordje ELSEVIER, 2018, Amsterdam [u.a.] |
---|---|
Übergeordnetes Werk: |
volume:107 ; year:2020 ; pages:0 |
Links: |
---|
DOI / URN: |
10.1016/j.pmatsci.2019.100599 |
---|
Katalog-ID: |
ELV048151564 |
---|
LEADER | 01000caa a22002652 4500 | ||
---|---|---|---|
001 | ELV048151564 | ||
003 | DE-627 | ||
005 | 20230626021305.0 | ||
007 | cr uuu---uuuuu | ||
008 | 191023s2020 xx |||||o 00| ||eng c | ||
024 | 7 | |a 10.1016/j.pmatsci.2019.100599 |2 doi | |
028 | 5 | 2 | |a GBV00000000000776.pica |
035 | |a (DE-627)ELV048151564 | ||
035 | |a (ELSEVIER)S0079-6425(19)30081-7 | ||
040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
041 | |a eng | ||
082 | 0 | 4 | |a 610 |q VZ |
084 | |a 15,3 |2 ssgn | ||
084 | |a PHARM |q DE-84 |2 fid | ||
084 | |a 44.40 |2 bkl | ||
100 | 1 | |a Guo, Xing |e verfasserin |4 aut | |
245 | 1 | 0 | |a Multifunctional nanoplatforms for subcellular delivery of drugs in cancer therapy |
264 | 1 | |c 2020transfer abstract | |
336 | |a nicht spezifiziert |b zzz |2 rdacontent | ||
337 | |a nicht spezifiziert |b z |2 rdamedia | ||
338 | |a nicht spezifiziert |b zu |2 rdacarrier | ||
520 | |a To achieve highly effective treatment to diseases, successful delivery of drugs with a carrier into the specific organelles (nucleus, mitochondria, lysosomes, etc.) is of great importance. Targeted delivery based on nanoparticle (NP)-based drug delivery systems (NDDSs) is mainly focused on cell-membrane targeting. In this review we summarize researches on organelle-specific drug delivery with multifunctional NPs. Many effective strategies are introduced for functionalizing these NPs by altering their chemical composition or by grafting functional groups onto their surface for improving organelle-targeting ability. Only when the concentrationof released drugs becomes high enough will they interact with molecular targets on specific organelles to induce tumor cell apoptosis. Organelle-specific delivery will become one of the primary goals for targeted drug delivery research. | ||
520 | |a To achieve highly effective treatment to diseases, successful delivery of drugs with a carrier into the specific organelles (nucleus, mitochondria, lysosomes, etc.) is of great importance. Targeted delivery based on nanoparticle (NP)-based drug delivery systems (NDDSs) is mainly focused on cell-membrane targeting. In this review we summarize researches on organelle-specific drug delivery with multifunctional NPs. Many effective strategies are introduced for functionalizing these NPs by altering their chemical composition or by grafting functional groups onto their surface for improving organelle-targeting ability. Only when the concentrationof released drugs becomes high enough will they interact with molecular targets on specific organelles to induce tumor cell apoptosis. Organelle-specific delivery will become one of the primary goals for targeted drug delivery research. | ||
650 | 7 | |a TfR |2 Elsevier | |
650 | 7 | |a BBB |2 Elsevier | |
650 | 7 | |a PS |2 Elsevier | |
650 | 7 | |a EPR |2 Elsevier | |
650 | 7 | |a MHC |2 Elsevier | |
650 | 7 | |a HT |2 Elsevier | |
650 | 7 | |a OLL |2 Elsevier | |
650 | 7 | |a GLS |2 Elsevier | |
650 | 7 | |a Nups |2 Elsevier | |
650 | 7 | |a PI3K |2 Elsevier | |
650 | 7 | |a UPR |2 Elsevier | |
650 | 7 | |a IA |2 Elsevier | |
650 | 7 | |a CME |2 Elsevier | |
650 | 7 | |a NDDSs |2 Elsevier | |
650 | 7 | |a R8 |2 Elsevier | |
650 | 7 | |a DOX |2 Elsevier | |
650 | 7 | |a OMM |2 Elsevier | |
650 | 7 | |a PAMAM |2 Elsevier | |
650 | 7 | |a AR |2 Elsevier | |
650 | 7 | |a DLCs |2 Elsevier | |
650 | 7 | |a SV40 |2 Elsevier | |
650 | 7 | |a LCST |2 Elsevier | |
650 | 7 | |a Ab |2 Elsevier | |
650 | 7 | |a ABC |2 Elsevier | |
650 | 7 | |a Ad |2 Elsevier | |
650 | 7 | |a MCF-7 |2 Elsevier | |
650 | 7 | |a Ir |2 Elsevier | |
650 | 7 | |a CvME |2 Elsevier | |
650 | 7 | |a CPPs |2 Elsevier | |
650 | 7 | |a HeLa |2 Elsevier | |
650 | 7 | |a DQA |2 Elsevier | |
650 | 7 | |a LSDs |2 Elsevier | |
650 | 7 | |a TPP |2 Elsevier | |
650 | 7 | |a NCs |2 Elsevier | |
650 | 7 | |a B55 |2 Elsevier | |
650 | 7 | |a Phis |2 Elsevier | |
650 | 7 | |a HIV |2 Elsevier | |
650 | 7 | |a ICP |2 Elsevier | |
650 | 7 | |a NER |2 Elsevier | |
650 | 7 | |a ATP |2 Elsevier | |
650 | 7 | |a CPT |2 Elsevier | |
650 | 7 | |a TAT |2 Elsevier | |
650 | 7 | |a HNPs |2 Elsevier | |
650 | 7 | |a LRP |2 Elsevier | |
650 | 7 | |a VNB |2 Elsevier | |
650 | 7 | |a ELS |2 Elsevier | |
650 | 7 | |a MTS |2 Elsevier | |
650 | 7 | |a IUSs |2 Elsevier | |
650 | 7 | |a Tf |2 Elsevier | |
650 | 7 | |a MD |2 Elsevier | |
650 | 7 | |a mTOR |2 Elsevier | |
650 | 7 | |a SNPs |2 Elsevier | |
650 | 7 | |a Gb3 |2 Elsevier | |
650 | 7 | |a IDS |2 Elsevier | |
650 | 7 | |a MDR |2 Elsevier | |
650 | 7 | |a NLSs |2 Elsevier | |
650 | 7 | |a PSD |2 Elsevier | |
650 | 7 | |a P-gp |2 Elsevier | |
650 | 7 | |a VAMP |2 Elsevier | |
650 | 7 | |a IMM |2 Elsevier | |
650 | 7 | |a N9 |2 Elsevier | |
650 | 7 | |a MAPK |2 Elsevier | |
650 | 7 | |a ER |2 Elsevier | |
650 | 7 | |a IMS |2 Elsevier | |
650 | 7 | |a RGD |2 Elsevier | |
650 | 7 | |a ERHNPs |2 Elsevier | |
650 | 7 | |a LCVs |2 Elsevier | |
650 | 7 | |a NE |2 Elsevier | |
650 | 7 | |a ROS |2 Elsevier | |
650 | 7 | |a PCL |2 Elsevier | |
650 | 7 | |a ANG |2 Elsevier | |
650 | 7 | |a HPMA |2 Elsevier | |
650 | 7 | |a QDs |2 Elsevier | |
650 | 7 | |a NP |2 Elsevier | |
650 | 7 | |a LIMP |2 Elsevier | |
650 | 7 | |a PLA |2 Elsevier | |
650 | 7 | |a GILT |2 Elsevier | |
650 | 7 | |a EGFP |2 Elsevier | |
650 | 7 | |a FR |2 Elsevier | |
650 | 7 | |a MSNP |2 Elsevier | |
650 | 7 | |a STxB |2 Elsevier | |
650 | 7 | |a EGFR |2 Elsevier | |
650 | 7 | |a PLL |2 Elsevier | |
650 | 7 | |a AuNPs |2 Elsevier | |
650 | 7 | |a HepG2 |2 Elsevier | |
650 | 7 | |a GA |2 Elsevier | |
650 | 7 | |a GSH |2 Elsevier | |
650 | 7 | |a DOPE |2 Elsevier | |
650 | 7 | |a ApDCs |2 Elsevier | |
650 | 7 | |a GI |2 Elsevier | |
650 | 7 | |a EGF |2 Elsevier | |
650 | 7 | |a Fab |2 Elsevier | |
650 | 7 | |a M6P |2 Elsevier | |
650 | 7 | |a FPs |2 Elsevier | |
650 | 7 | |a RAW 264.7 |2 Elsevier | |
650 | 7 | |a SNAP |2 Elsevier | |
650 | 7 | |a GALA |2 Elsevier | |
650 | 7 | |a LMP |2 Elsevier | |
650 | 7 | |a PEG |2 Elsevier | |
650 | 7 | |a PLGA |2 Elsevier | |
650 | 7 | |a PEI |2 Elsevier | |
650 | 7 | |a NPCs |2 Elsevier | |
650 | 7 | |a DOTAP |2 Elsevier | |
650 | 7 | |a LAMP |2 Elsevier | |
650 | 7 | |a DMMA |2 Elsevier | |
700 | 1 | |a Wei, Xiao |4 oth | |
700 | 1 | |a Chen, Zi |4 oth | |
700 | 1 | |a Zhang, Xiaobin |4 oth | |
700 | 1 | |a Yang, Guang |4 oth | |
700 | 1 | |a Zhou, Shaobing |4 oth | |
773 | 0 | 8 | |i Enthalten in |n Elsevier Science |a Medarević, Djordje ELSEVIER |t Assessing the potential of solid dispersions to improve dissolution rate and bioavailability of valsartan: |d 2018 |g Amsterdam [u.a.] |w (DE-627)ELV000698369 |
773 | 1 | 8 | |g volume:107 |g year:2020 |g pages:0 |
856 | 4 | 0 | |u https://doi.org/10.1016/j.pmatsci.2019.100599 |3 Volltext |
912 | |a GBV_USEFLAG_U | ||
912 | |a GBV_ELV | ||
912 | |a SYSFLAG_U | ||
912 | |a FID-PHARM | ||
912 | |a SSG-OLC-PHA | ||
912 | |a SSG-OPC-PHA | ||
936 | b | k | |a 44.40 |j Pharmazie |j Pharmazeutika |q VZ |
951 | |a AR | ||
952 | |d 107 |j 2020 |h 0 |
author_variant |
x g xg |
---|---|
matchkey_str |
guoxingweixiaochenzizhangxiaobinyangguan:2020----:utfntoannpafrsosbellreieyfr |
hierarchy_sort_str |
2020transfer abstract |
bklnumber |
44.40 |
publishDate |
2020 |
allfields |
10.1016/j.pmatsci.2019.100599 doi GBV00000000000776.pica (DE-627)ELV048151564 (ELSEVIER)S0079-6425(19)30081-7 DE-627 ger DE-627 rakwb eng 610 VZ 15,3 ssgn PHARM DE-84 fid 44.40 bkl Guo, Xing verfasserin aut Multifunctional nanoplatforms for subcellular delivery of drugs in cancer therapy 2020transfer abstract nicht spezifiziert zzz rdacontent nicht spezifiziert z rdamedia nicht spezifiziert zu rdacarrier To achieve highly effective treatment to diseases, successful delivery of drugs with a carrier into the specific organelles (nucleus, mitochondria, lysosomes, etc.) is of great importance. Targeted delivery based on nanoparticle (NP)-based drug delivery systems (NDDSs) is mainly focused on cell-membrane targeting. In this review we summarize researches on organelle-specific drug delivery with multifunctional NPs. Many effective strategies are introduced for functionalizing these NPs by altering their chemical composition or by grafting functional groups onto their surface for improving organelle-targeting ability. Only when the concentrationof released drugs becomes high enough will they interact with molecular targets on specific organelles to induce tumor cell apoptosis. Organelle-specific delivery will become one of the primary goals for targeted drug delivery research. To achieve highly effective treatment to diseases, successful delivery of drugs with a carrier into the specific organelles (nucleus, mitochondria, lysosomes, etc.) is of great importance. Targeted delivery based on nanoparticle (NP)-based drug delivery systems (NDDSs) is mainly focused on cell-membrane targeting. In this review we summarize researches on organelle-specific drug delivery with multifunctional NPs. Many effective strategies are introduced for functionalizing these NPs by altering their chemical composition or by grafting functional groups onto their surface for improving organelle-targeting ability. Only when the concentrationof released drugs becomes high enough will they interact with molecular targets on specific organelles to induce tumor cell apoptosis. Organelle-specific delivery will become one of the primary goals for targeted drug delivery research. TfR Elsevier BBB Elsevier PS Elsevier EPR Elsevier MHC Elsevier HT Elsevier OLL Elsevier GLS Elsevier Nups Elsevier PI3K Elsevier UPR Elsevier IA Elsevier CME Elsevier NDDSs Elsevier R8 Elsevier DOX Elsevier OMM Elsevier PAMAM Elsevier AR Elsevier DLCs Elsevier SV40 Elsevier LCST Elsevier Ab Elsevier ABC Elsevier Ad Elsevier MCF-7 Elsevier Ir Elsevier CvME Elsevier CPPs Elsevier HeLa Elsevier DQA Elsevier LSDs Elsevier TPP Elsevier NCs Elsevier B55 Elsevier Phis Elsevier HIV Elsevier ICP Elsevier NER Elsevier ATP Elsevier CPT Elsevier TAT Elsevier HNPs Elsevier LRP Elsevier VNB Elsevier ELS Elsevier MTS Elsevier IUSs Elsevier Tf Elsevier MD Elsevier mTOR Elsevier SNPs Elsevier Gb3 Elsevier IDS Elsevier MDR Elsevier NLSs Elsevier PSD Elsevier P-gp Elsevier VAMP Elsevier IMM Elsevier N9 Elsevier MAPK Elsevier ER Elsevier IMS Elsevier RGD Elsevier ERHNPs Elsevier LCVs Elsevier NE Elsevier ROS Elsevier PCL Elsevier ANG Elsevier HPMA Elsevier QDs Elsevier NP Elsevier LIMP Elsevier PLA Elsevier GILT Elsevier EGFP Elsevier FR Elsevier MSNP Elsevier STxB Elsevier EGFR Elsevier PLL Elsevier AuNPs Elsevier HepG2 Elsevier GA Elsevier GSH Elsevier DOPE Elsevier ApDCs Elsevier GI Elsevier EGF Elsevier Fab Elsevier M6P Elsevier FPs Elsevier RAW 264.7 Elsevier SNAP Elsevier GALA Elsevier LMP Elsevier PEG Elsevier PLGA Elsevier PEI Elsevier NPCs Elsevier DOTAP Elsevier LAMP Elsevier DMMA Elsevier Wei, Xiao oth Chen, Zi oth Zhang, Xiaobin oth Yang, Guang oth Zhou, Shaobing oth Enthalten in Elsevier Science Medarević, Djordje ELSEVIER Assessing the potential of solid dispersions to improve dissolution rate and bioavailability of valsartan: 2018 Amsterdam [u.a.] (DE-627)ELV000698369 volume:107 year:2020 pages:0 https://doi.org/10.1016/j.pmatsci.2019.100599 Volltext GBV_USEFLAG_U GBV_ELV SYSFLAG_U FID-PHARM SSG-OLC-PHA SSG-OPC-PHA 44.40 Pharmazie Pharmazeutika VZ AR 107 2020 0 |
spelling |
10.1016/j.pmatsci.2019.100599 doi GBV00000000000776.pica (DE-627)ELV048151564 (ELSEVIER)S0079-6425(19)30081-7 DE-627 ger DE-627 rakwb eng 610 VZ 15,3 ssgn PHARM DE-84 fid 44.40 bkl Guo, Xing verfasserin aut Multifunctional nanoplatforms for subcellular delivery of drugs in cancer therapy 2020transfer abstract nicht spezifiziert zzz rdacontent nicht spezifiziert z rdamedia nicht spezifiziert zu rdacarrier To achieve highly effective treatment to diseases, successful delivery of drugs with a carrier into the specific organelles (nucleus, mitochondria, lysosomes, etc.) is of great importance. Targeted delivery based on nanoparticle (NP)-based drug delivery systems (NDDSs) is mainly focused on cell-membrane targeting. In this review we summarize researches on organelle-specific drug delivery with multifunctional NPs. Many effective strategies are introduced for functionalizing these NPs by altering their chemical composition or by grafting functional groups onto their surface for improving organelle-targeting ability. Only when the concentrationof released drugs becomes high enough will they interact with molecular targets on specific organelles to induce tumor cell apoptosis. Organelle-specific delivery will become one of the primary goals for targeted drug delivery research. To achieve highly effective treatment to diseases, successful delivery of drugs with a carrier into the specific organelles (nucleus, mitochondria, lysosomes, etc.) is of great importance. Targeted delivery based on nanoparticle (NP)-based drug delivery systems (NDDSs) is mainly focused on cell-membrane targeting. In this review we summarize researches on organelle-specific drug delivery with multifunctional NPs. Many effective strategies are introduced for functionalizing these NPs by altering their chemical composition or by grafting functional groups onto their surface for improving organelle-targeting ability. Only when the concentrationof released drugs becomes high enough will they interact with molecular targets on specific organelles to induce tumor cell apoptosis. Organelle-specific delivery will become one of the primary goals for targeted drug delivery research. TfR Elsevier BBB Elsevier PS Elsevier EPR Elsevier MHC Elsevier HT Elsevier OLL Elsevier GLS Elsevier Nups Elsevier PI3K Elsevier UPR Elsevier IA Elsevier CME Elsevier NDDSs Elsevier R8 Elsevier DOX Elsevier OMM Elsevier PAMAM Elsevier AR Elsevier DLCs Elsevier SV40 Elsevier LCST Elsevier Ab Elsevier ABC Elsevier Ad Elsevier MCF-7 Elsevier Ir Elsevier CvME Elsevier CPPs Elsevier HeLa Elsevier DQA Elsevier LSDs Elsevier TPP Elsevier NCs Elsevier B55 Elsevier Phis Elsevier HIV Elsevier ICP Elsevier NER Elsevier ATP Elsevier CPT Elsevier TAT Elsevier HNPs Elsevier LRP Elsevier VNB Elsevier ELS Elsevier MTS Elsevier IUSs Elsevier Tf Elsevier MD Elsevier mTOR Elsevier SNPs Elsevier Gb3 Elsevier IDS Elsevier MDR Elsevier NLSs Elsevier PSD Elsevier P-gp Elsevier VAMP Elsevier IMM Elsevier N9 Elsevier MAPK Elsevier ER Elsevier IMS Elsevier RGD Elsevier ERHNPs Elsevier LCVs Elsevier NE Elsevier ROS Elsevier PCL Elsevier ANG Elsevier HPMA Elsevier QDs Elsevier NP Elsevier LIMP Elsevier PLA Elsevier GILT Elsevier EGFP Elsevier FR Elsevier MSNP Elsevier STxB Elsevier EGFR Elsevier PLL Elsevier AuNPs Elsevier HepG2 Elsevier GA Elsevier GSH Elsevier DOPE Elsevier ApDCs Elsevier GI Elsevier EGF Elsevier Fab Elsevier M6P Elsevier FPs Elsevier RAW 264.7 Elsevier SNAP Elsevier GALA Elsevier LMP Elsevier PEG Elsevier PLGA Elsevier PEI Elsevier NPCs Elsevier DOTAP Elsevier LAMP Elsevier DMMA Elsevier Wei, Xiao oth Chen, Zi oth Zhang, Xiaobin oth Yang, Guang oth Zhou, Shaobing oth Enthalten in Elsevier Science Medarević, Djordje ELSEVIER Assessing the potential of solid dispersions to improve dissolution rate and bioavailability of valsartan: 2018 Amsterdam [u.a.] (DE-627)ELV000698369 volume:107 year:2020 pages:0 https://doi.org/10.1016/j.pmatsci.2019.100599 Volltext GBV_USEFLAG_U GBV_ELV SYSFLAG_U FID-PHARM SSG-OLC-PHA SSG-OPC-PHA 44.40 Pharmazie Pharmazeutika VZ AR 107 2020 0 |
allfields_unstemmed |
10.1016/j.pmatsci.2019.100599 doi GBV00000000000776.pica (DE-627)ELV048151564 (ELSEVIER)S0079-6425(19)30081-7 DE-627 ger DE-627 rakwb eng 610 VZ 15,3 ssgn PHARM DE-84 fid 44.40 bkl Guo, Xing verfasserin aut Multifunctional nanoplatforms for subcellular delivery of drugs in cancer therapy 2020transfer abstract nicht spezifiziert zzz rdacontent nicht spezifiziert z rdamedia nicht spezifiziert zu rdacarrier To achieve highly effective treatment to diseases, successful delivery of drugs with a carrier into the specific organelles (nucleus, mitochondria, lysosomes, etc.) is of great importance. Targeted delivery based on nanoparticle (NP)-based drug delivery systems (NDDSs) is mainly focused on cell-membrane targeting. In this review we summarize researches on organelle-specific drug delivery with multifunctional NPs. Many effective strategies are introduced for functionalizing these NPs by altering their chemical composition or by grafting functional groups onto their surface for improving organelle-targeting ability. Only when the concentrationof released drugs becomes high enough will they interact with molecular targets on specific organelles to induce tumor cell apoptosis. Organelle-specific delivery will become one of the primary goals for targeted drug delivery research. To achieve highly effective treatment to diseases, successful delivery of drugs with a carrier into the specific organelles (nucleus, mitochondria, lysosomes, etc.) is of great importance. Targeted delivery based on nanoparticle (NP)-based drug delivery systems (NDDSs) is mainly focused on cell-membrane targeting. In this review we summarize researches on organelle-specific drug delivery with multifunctional NPs. Many effective strategies are introduced for functionalizing these NPs by altering their chemical composition or by grafting functional groups onto their surface for improving organelle-targeting ability. Only when the concentrationof released drugs becomes high enough will they interact with molecular targets on specific organelles to induce tumor cell apoptosis. Organelle-specific delivery will become one of the primary goals for targeted drug delivery research. TfR Elsevier BBB Elsevier PS Elsevier EPR Elsevier MHC Elsevier HT Elsevier OLL Elsevier GLS Elsevier Nups Elsevier PI3K Elsevier UPR Elsevier IA Elsevier CME Elsevier NDDSs Elsevier R8 Elsevier DOX Elsevier OMM Elsevier PAMAM Elsevier AR Elsevier DLCs Elsevier SV40 Elsevier LCST Elsevier Ab Elsevier ABC Elsevier Ad Elsevier MCF-7 Elsevier Ir Elsevier CvME Elsevier CPPs Elsevier HeLa Elsevier DQA Elsevier LSDs Elsevier TPP Elsevier NCs Elsevier B55 Elsevier Phis Elsevier HIV Elsevier ICP Elsevier NER Elsevier ATP Elsevier CPT Elsevier TAT Elsevier HNPs Elsevier LRP Elsevier VNB Elsevier ELS Elsevier MTS Elsevier IUSs Elsevier Tf Elsevier MD Elsevier mTOR Elsevier SNPs Elsevier Gb3 Elsevier IDS Elsevier MDR Elsevier NLSs Elsevier PSD Elsevier P-gp Elsevier VAMP Elsevier IMM Elsevier N9 Elsevier MAPK Elsevier ER Elsevier IMS Elsevier RGD Elsevier ERHNPs Elsevier LCVs Elsevier NE Elsevier ROS Elsevier PCL Elsevier ANG Elsevier HPMA Elsevier QDs Elsevier NP Elsevier LIMP Elsevier PLA Elsevier GILT Elsevier EGFP Elsevier FR Elsevier MSNP Elsevier STxB Elsevier EGFR Elsevier PLL Elsevier AuNPs Elsevier HepG2 Elsevier GA Elsevier GSH Elsevier DOPE Elsevier ApDCs Elsevier GI Elsevier EGF Elsevier Fab Elsevier M6P Elsevier FPs Elsevier RAW 264.7 Elsevier SNAP Elsevier GALA Elsevier LMP Elsevier PEG Elsevier PLGA Elsevier PEI Elsevier NPCs Elsevier DOTAP Elsevier LAMP Elsevier DMMA Elsevier Wei, Xiao oth Chen, Zi oth Zhang, Xiaobin oth Yang, Guang oth Zhou, Shaobing oth Enthalten in Elsevier Science Medarević, Djordje ELSEVIER Assessing the potential of solid dispersions to improve dissolution rate and bioavailability of valsartan: 2018 Amsterdam [u.a.] (DE-627)ELV000698369 volume:107 year:2020 pages:0 https://doi.org/10.1016/j.pmatsci.2019.100599 Volltext GBV_USEFLAG_U GBV_ELV SYSFLAG_U FID-PHARM SSG-OLC-PHA SSG-OPC-PHA 44.40 Pharmazie Pharmazeutika VZ AR 107 2020 0 |
allfieldsGer |
10.1016/j.pmatsci.2019.100599 doi GBV00000000000776.pica (DE-627)ELV048151564 (ELSEVIER)S0079-6425(19)30081-7 DE-627 ger DE-627 rakwb eng 610 VZ 15,3 ssgn PHARM DE-84 fid 44.40 bkl Guo, Xing verfasserin aut Multifunctional nanoplatforms for subcellular delivery of drugs in cancer therapy 2020transfer abstract nicht spezifiziert zzz rdacontent nicht spezifiziert z rdamedia nicht spezifiziert zu rdacarrier To achieve highly effective treatment to diseases, successful delivery of drugs with a carrier into the specific organelles (nucleus, mitochondria, lysosomes, etc.) is of great importance. Targeted delivery based on nanoparticle (NP)-based drug delivery systems (NDDSs) is mainly focused on cell-membrane targeting. In this review we summarize researches on organelle-specific drug delivery with multifunctional NPs. Many effective strategies are introduced for functionalizing these NPs by altering their chemical composition or by grafting functional groups onto their surface for improving organelle-targeting ability. Only when the concentrationof released drugs becomes high enough will they interact with molecular targets on specific organelles to induce tumor cell apoptosis. Organelle-specific delivery will become one of the primary goals for targeted drug delivery research. To achieve highly effective treatment to diseases, successful delivery of drugs with a carrier into the specific organelles (nucleus, mitochondria, lysosomes, etc.) is of great importance. Targeted delivery based on nanoparticle (NP)-based drug delivery systems (NDDSs) is mainly focused on cell-membrane targeting. In this review we summarize researches on organelle-specific drug delivery with multifunctional NPs. Many effective strategies are introduced for functionalizing these NPs by altering their chemical composition or by grafting functional groups onto their surface for improving organelle-targeting ability. Only when the concentrationof released drugs becomes high enough will they interact with molecular targets on specific organelles to induce tumor cell apoptosis. Organelle-specific delivery will become one of the primary goals for targeted drug delivery research. TfR Elsevier BBB Elsevier PS Elsevier EPR Elsevier MHC Elsevier HT Elsevier OLL Elsevier GLS Elsevier Nups Elsevier PI3K Elsevier UPR Elsevier IA Elsevier CME Elsevier NDDSs Elsevier R8 Elsevier DOX Elsevier OMM Elsevier PAMAM Elsevier AR Elsevier DLCs Elsevier SV40 Elsevier LCST Elsevier Ab Elsevier ABC Elsevier Ad Elsevier MCF-7 Elsevier Ir Elsevier CvME Elsevier CPPs Elsevier HeLa Elsevier DQA Elsevier LSDs Elsevier TPP Elsevier NCs Elsevier B55 Elsevier Phis Elsevier HIV Elsevier ICP Elsevier NER Elsevier ATP Elsevier CPT Elsevier TAT Elsevier HNPs Elsevier LRP Elsevier VNB Elsevier ELS Elsevier MTS Elsevier IUSs Elsevier Tf Elsevier MD Elsevier mTOR Elsevier SNPs Elsevier Gb3 Elsevier IDS Elsevier MDR Elsevier NLSs Elsevier PSD Elsevier P-gp Elsevier VAMP Elsevier IMM Elsevier N9 Elsevier MAPK Elsevier ER Elsevier IMS Elsevier RGD Elsevier ERHNPs Elsevier LCVs Elsevier NE Elsevier ROS Elsevier PCL Elsevier ANG Elsevier HPMA Elsevier QDs Elsevier NP Elsevier LIMP Elsevier PLA Elsevier GILT Elsevier EGFP Elsevier FR Elsevier MSNP Elsevier STxB Elsevier EGFR Elsevier PLL Elsevier AuNPs Elsevier HepG2 Elsevier GA Elsevier GSH Elsevier DOPE Elsevier ApDCs Elsevier GI Elsevier EGF Elsevier Fab Elsevier M6P Elsevier FPs Elsevier RAW 264.7 Elsevier SNAP Elsevier GALA Elsevier LMP Elsevier PEG Elsevier PLGA Elsevier PEI Elsevier NPCs Elsevier DOTAP Elsevier LAMP Elsevier DMMA Elsevier Wei, Xiao oth Chen, Zi oth Zhang, Xiaobin oth Yang, Guang oth Zhou, Shaobing oth Enthalten in Elsevier Science Medarević, Djordje ELSEVIER Assessing the potential of solid dispersions to improve dissolution rate and bioavailability of valsartan: 2018 Amsterdam [u.a.] (DE-627)ELV000698369 volume:107 year:2020 pages:0 https://doi.org/10.1016/j.pmatsci.2019.100599 Volltext GBV_USEFLAG_U GBV_ELV SYSFLAG_U FID-PHARM SSG-OLC-PHA SSG-OPC-PHA 44.40 Pharmazie Pharmazeutika VZ AR 107 2020 0 |
allfieldsSound |
10.1016/j.pmatsci.2019.100599 doi GBV00000000000776.pica (DE-627)ELV048151564 (ELSEVIER)S0079-6425(19)30081-7 DE-627 ger DE-627 rakwb eng 610 VZ 15,3 ssgn PHARM DE-84 fid 44.40 bkl Guo, Xing verfasserin aut Multifunctional nanoplatforms for subcellular delivery of drugs in cancer therapy 2020transfer abstract nicht spezifiziert zzz rdacontent nicht spezifiziert z rdamedia nicht spezifiziert zu rdacarrier To achieve highly effective treatment to diseases, successful delivery of drugs with a carrier into the specific organelles (nucleus, mitochondria, lysosomes, etc.) is of great importance. Targeted delivery based on nanoparticle (NP)-based drug delivery systems (NDDSs) is mainly focused on cell-membrane targeting. In this review we summarize researches on organelle-specific drug delivery with multifunctional NPs. Many effective strategies are introduced for functionalizing these NPs by altering their chemical composition or by grafting functional groups onto their surface for improving organelle-targeting ability. Only when the concentrationof released drugs becomes high enough will they interact with molecular targets on specific organelles to induce tumor cell apoptosis. Organelle-specific delivery will become one of the primary goals for targeted drug delivery research. To achieve highly effective treatment to diseases, successful delivery of drugs with a carrier into the specific organelles (nucleus, mitochondria, lysosomes, etc.) is of great importance. Targeted delivery based on nanoparticle (NP)-based drug delivery systems (NDDSs) is mainly focused on cell-membrane targeting. In this review we summarize researches on organelle-specific drug delivery with multifunctional NPs. Many effective strategies are introduced for functionalizing these NPs by altering their chemical composition or by grafting functional groups onto their surface for improving organelle-targeting ability. Only when the concentrationof released drugs becomes high enough will they interact with molecular targets on specific organelles to induce tumor cell apoptosis. Organelle-specific delivery will become one of the primary goals for targeted drug delivery research. TfR Elsevier BBB Elsevier PS Elsevier EPR Elsevier MHC Elsevier HT Elsevier OLL Elsevier GLS Elsevier Nups Elsevier PI3K Elsevier UPR Elsevier IA Elsevier CME Elsevier NDDSs Elsevier R8 Elsevier DOX Elsevier OMM Elsevier PAMAM Elsevier AR Elsevier DLCs Elsevier SV40 Elsevier LCST Elsevier Ab Elsevier ABC Elsevier Ad Elsevier MCF-7 Elsevier Ir Elsevier CvME Elsevier CPPs Elsevier HeLa Elsevier DQA Elsevier LSDs Elsevier TPP Elsevier NCs Elsevier B55 Elsevier Phis Elsevier HIV Elsevier ICP Elsevier NER Elsevier ATP Elsevier CPT Elsevier TAT Elsevier HNPs Elsevier LRP Elsevier VNB Elsevier ELS Elsevier MTS Elsevier IUSs Elsevier Tf Elsevier MD Elsevier mTOR Elsevier SNPs Elsevier Gb3 Elsevier IDS Elsevier MDR Elsevier NLSs Elsevier PSD Elsevier P-gp Elsevier VAMP Elsevier IMM Elsevier N9 Elsevier MAPK Elsevier ER Elsevier IMS Elsevier RGD Elsevier ERHNPs Elsevier LCVs Elsevier NE Elsevier ROS Elsevier PCL Elsevier ANG Elsevier HPMA Elsevier QDs Elsevier NP Elsevier LIMP Elsevier PLA Elsevier GILT Elsevier EGFP Elsevier FR Elsevier MSNP Elsevier STxB Elsevier EGFR Elsevier PLL Elsevier AuNPs Elsevier HepG2 Elsevier GA Elsevier GSH Elsevier DOPE Elsevier ApDCs Elsevier GI Elsevier EGF Elsevier Fab Elsevier M6P Elsevier FPs Elsevier RAW 264.7 Elsevier SNAP Elsevier GALA Elsevier LMP Elsevier PEG Elsevier PLGA Elsevier PEI Elsevier NPCs Elsevier DOTAP Elsevier LAMP Elsevier DMMA Elsevier Wei, Xiao oth Chen, Zi oth Zhang, Xiaobin oth Yang, Guang oth Zhou, Shaobing oth Enthalten in Elsevier Science Medarević, Djordje ELSEVIER Assessing the potential of solid dispersions to improve dissolution rate and bioavailability of valsartan: 2018 Amsterdam [u.a.] (DE-627)ELV000698369 volume:107 year:2020 pages:0 https://doi.org/10.1016/j.pmatsci.2019.100599 Volltext GBV_USEFLAG_U GBV_ELV SYSFLAG_U FID-PHARM SSG-OLC-PHA SSG-OPC-PHA 44.40 Pharmazie Pharmazeutika VZ AR 107 2020 0 |
language |
English |
source |
Enthalten in Assessing the potential of solid dispersions to improve dissolution rate and bioavailability of valsartan: Amsterdam [u.a.] volume:107 year:2020 pages:0 |
sourceStr |
Enthalten in Assessing the potential of solid dispersions to improve dissolution rate and bioavailability of valsartan: Amsterdam [u.a.] volume:107 year:2020 pages:0 |
format_phy_str_mv |
Article |
bklname |
Pharmazie Pharmazeutika |
institution |
findex.gbv.de |
topic_facet |
TfR BBB PS EPR MHC HT OLL GLS Nups PI3K UPR IA CME NDDSs R8 DOX OMM PAMAM AR DLCs SV40 LCST Ab ABC Ad MCF-7 Ir CvME CPPs HeLa DQA LSDs TPP NCs B55 Phis HIV ICP NER ATP CPT TAT HNPs LRP VNB ELS MTS IUSs Tf MD mTOR SNPs Gb3 IDS MDR NLSs PSD P-gp VAMP IMM N9 MAPK ER IMS RGD ERHNPs LCVs NE ROS PCL ANG HPMA QDs NP LIMP PLA GILT EGFP FR MSNP STxB EGFR PLL AuNPs HepG2 GA GSH DOPE ApDCs GI EGF Fab M6P FPs RAW 264.7 SNAP GALA LMP PEG PLGA PEI NPCs DOTAP LAMP DMMA |
dewey-raw |
610 |
isfreeaccess_bool |
false |
container_title |
Assessing the potential of solid dispersions to improve dissolution rate and bioavailability of valsartan: |
authorswithroles_txt_mv |
Guo, Xing @@aut@@ Wei, Xiao @@oth@@ Chen, Zi @@oth@@ Zhang, Xiaobin @@oth@@ Yang, Guang @@oth@@ Zhou, Shaobing @@oth@@ |
publishDateDaySort_date |
2020-01-01T00:00:00Z |
hierarchy_top_id |
ELV000698369 |
dewey-sort |
3610 |
id |
ELV048151564 |
language_de |
englisch |
fullrecord |
<?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>01000caa a22002652 4500</leader><controlfield tag="001">ELV048151564</controlfield><controlfield tag="003">DE-627</controlfield><controlfield tag="005">20230626021305.0</controlfield><controlfield tag="007">cr uuu---uuuuu</controlfield><controlfield tag="008">191023s2020 xx |||||o 00| ||eng c</controlfield><datafield tag="024" ind1="7" ind2=" "><subfield code="a">10.1016/j.pmatsci.2019.100599</subfield><subfield code="2">doi</subfield></datafield><datafield tag="028" ind1="5" ind2="2"><subfield code="a">GBV00000000000776.pica</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-627)ELV048151564</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(ELSEVIER)S0079-6425(19)30081-7</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-627</subfield><subfield code="b">ger</subfield><subfield code="c">DE-627</subfield><subfield code="e">rakwb</subfield></datafield><datafield tag="041" ind1=" " ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="082" ind1="0" ind2="4"><subfield code="a">610</subfield><subfield code="q">VZ</subfield></datafield><datafield tag="084" ind1=" " ind2=" "><subfield code="a">15,3</subfield><subfield code="2">ssgn</subfield></datafield><datafield tag="084" ind1=" " ind2=" "><subfield code="a">PHARM</subfield><subfield code="q">DE-84</subfield><subfield code="2">fid</subfield></datafield><datafield tag="084" ind1=" " ind2=" "><subfield code="a">44.40</subfield><subfield code="2">bkl</subfield></datafield><datafield tag="100" ind1="1" ind2=" "><subfield code="a">Guo, Xing</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Multifunctional nanoplatforms for subcellular delivery of drugs in cancer therapy</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="c">2020transfer abstract</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">zzz</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">z</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">zu</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="520" ind1=" " ind2=" "><subfield code="a">To achieve highly effective treatment to diseases, successful delivery of drugs with a carrier into the specific organelles (nucleus, mitochondria, lysosomes, etc.) is of great importance. Targeted delivery based on nanoparticle (NP)-based drug delivery systems (NDDSs) is mainly focused on cell-membrane targeting. In this review we summarize researches on organelle-specific drug delivery with multifunctional NPs. Many effective strategies are introduced for functionalizing these NPs by altering their chemical composition or by grafting functional groups onto their surface for improving organelle-targeting ability. Only when the concentrationof released drugs becomes high enough will they interact with molecular targets on specific organelles to induce tumor cell apoptosis. Organelle-specific delivery will become one of the primary goals for targeted drug delivery research.</subfield></datafield><datafield tag="520" ind1=" " ind2=" "><subfield code="a">To achieve highly effective treatment to diseases, successful delivery of drugs with a carrier into the specific organelles (nucleus, mitochondria, lysosomes, etc.) is of great importance. Targeted delivery based on nanoparticle (NP)-based drug delivery systems (NDDSs) is mainly focused on cell-membrane targeting. In this review we summarize researches on organelle-specific drug delivery with multifunctional NPs. Many effective strategies are introduced for functionalizing these NPs by altering their chemical composition or by grafting functional groups onto their surface for improving organelle-targeting ability. Only when the concentrationof released drugs becomes high enough will they interact with molecular targets on specific organelles to induce tumor cell apoptosis. Organelle-specific delivery will become one of the primary goals for targeted drug delivery research.</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">TfR</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">BBB</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">PS</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">EPR</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">MHC</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">HT</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">OLL</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">GLS</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Nups</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">PI3K</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">UPR</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">IA</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">CME</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">NDDSs</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">R8</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">DOX</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">OMM</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">PAMAM</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">AR</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">DLCs</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">SV40</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">LCST</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Ab</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">ABC</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Ad</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">MCF-7</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Ir</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">CvME</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">CPPs</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">HeLa</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">DQA</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">LSDs</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">TPP</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">NCs</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">B55</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Phis</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">HIV</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">ICP</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">NER</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">ATP</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">CPT</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">TAT</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">HNPs</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">LRP</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">VNB</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">ELS</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">MTS</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">IUSs</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Tf</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">MD</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">mTOR</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">SNPs</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Gb3</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">IDS</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">MDR</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">NLSs</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">PSD</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">P-gp</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">VAMP</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">IMM</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">N9</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">MAPK</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">ER</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">IMS</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">RGD</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">ERHNPs</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">LCVs</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">NE</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">ROS</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">PCL</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">ANG</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">HPMA</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">QDs</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">NP</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">LIMP</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">PLA</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">GILT</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">EGFP</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">FR</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">MSNP</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">STxB</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">EGFR</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">PLL</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">AuNPs</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">HepG2</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">GA</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">GSH</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">DOPE</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">ApDCs</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">GI</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">EGF</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Fab</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">M6P</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">FPs</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">RAW 264.7</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">SNAP</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">GALA</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">LMP</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">PEG</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">PLGA</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">PEI</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">NPCs</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">DOTAP</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">LAMP</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">DMMA</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Wei, Xiao</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Chen, Zi</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Zhang, Xiaobin</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Yang, Guang</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Zhou, Shaobing</subfield><subfield code="4">oth</subfield></datafield><datafield tag="773" ind1="0" ind2="8"><subfield code="i">Enthalten in</subfield><subfield code="n">Elsevier Science</subfield><subfield code="a">Medarević, Djordje ELSEVIER</subfield><subfield code="t">Assessing the potential of solid dispersions to improve dissolution rate and bioavailability of valsartan:</subfield><subfield code="d">2018</subfield><subfield code="g">Amsterdam [u.a.]</subfield><subfield code="w">(DE-627)ELV000698369</subfield></datafield><datafield tag="773" ind1="1" ind2="8"><subfield code="g">volume:107</subfield><subfield code="g">year:2020</subfield><subfield code="g">pages:0</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">https://doi.org/10.1016/j.pmatsci.2019.100599</subfield><subfield code="3">Volltext</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_USEFLAG_U</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ELV</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SYSFLAG_U</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">FID-PHARM</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SSG-OLC-PHA</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SSG-OPC-PHA</subfield></datafield><datafield tag="936" ind1="b" ind2="k"><subfield code="a">44.40</subfield><subfield code="j">Pharmazie</subfield><subfield code="j">Pharmazeutika</subfield><subfield code="q">VZ</subfield></datafield><datafield tag="951" ind1=" " ind2=" "><subfield code="a">AR</subfield></datafield><datafield tag="952" ind1=" " ind2=" "><subfield code="d">107</subfield><subfield code="j">2020</subfield><subfield code="h">0</subfield></datafield></record></collection>
|
author |
Guo, Xing |
spellingShingle |
Guo, Xing ddc 610 ssgn 15,3 fid PHARM bkl 44.40 Elsevier TfR Elsevier BBB Elsevier PS Elsevier EPR Elsevier MHC Elsevier HT Elsevier OLL Elsevier GLS Elsevier Nups Elsevier PI3K Elsevier UPR Elsevier IA Elsevier CME Elsevier NDDSs Elsevier R8 Elsevier DOX Elsevier OMM Elsevier PAMAM Elsevier AR Elsevier DLCs Elsevier SV40 Elsevier LCST Elsevier Ab Elsevier ABC Elsevier Ad Elsevier MCF-7 Elsevier Ir Elsevier CvME Elsevier CPPs Elsevier HeLa Elsevier DQA Elsevier LSDs Elsevier TPP Elsevier NCs Elsevier B55 Elsevier Phis Elsevier HIV Elsevier ICP Elsevier NER Elsevier ATP Elsevier CPT Elsevier TAT Elsevier HNPs Elsevier LRP Elsevier VNB Elsevier ELS Elsevier MTS Elsevier IUSs Elsevier Tf Elsevier MD Elsevier mTOR Elsevier SNPs Elsevier Gb3 Elsevier IDS Elsevier MDR Elsevier NLSs Elsevier PSD Elsevier P-gp Elsevier VAMP Elsevier IMM Elsevier N9 Elsevier MAPK Elsevier ER Elsevier IMS Elsevier RGD Elsevier ERHNPs Elsevier LCVs Elsevier NE Elsevier ROS Elsevier PCL Elsevier ANG Elsevier HPMA Elsevier QDs Elsevier NP Elsevier LIMP Elsevier PLA Elsevier GILT Elsevier EGFP Elsevier FR Elsevier MSNP Elsevier STxB Elsevier EGFR Elsevier PLL Elsevier AuNPs Elsevier HepG2 Elsevier GA Elsevier GSH Elsevier DOPE Elsevier ApDCs Elsevier GI Elsevier EGF Elsevier Fab Elsevier M6P Elsevier FPs Elsevier RAW 264.7 Elsevier SNAP Elsevier GALA Elsevier LMP Elsevier PEG Elsevier PLGA Elsevier PEI Elsevier NPCs Elsevier DOTAP Elsevier LAMP Elsevier DMMA Multifunctional nanoplatforms for subcellular delivery of drugs in cancer therapy |
authorStr |
Guo, Xing |
ppnlink_with_tag_str_mv |
@@773@@(DE-627)ELV000698369 |
format |
electronic Article |
dewey-ones |
610 - Medicine & health |
delete_txt_mv |
keep |
author_role |
aut |
collection |
elsevier |
remote_str |
true |
illustrated |
Not Illustrated |
topic_title |
610 VZ 15,3 ssgn PHARM DE-84 fid 44.40 bkl Multifunctional nanoplatforms for subcellular delivery of drugs in cancer therapy TfR Elsevier BBB Elsevier PS Elsevier EPR Elsevier MHC Elsevier HT Elsevier OLL Elsevier GLS Elsevier Nups Elsevier PI3K Elsevier UPR Elsevier IA Elsevier CME Elsevier NDDSs Elsevier R8 Elsevier DOX Elsevier OMM Elsevier PAMAM Elsevier AR Elsevier DLCs Elsevier SV40 Elsevier LCST Elsevier Ab Elsevier ABC Elsevier Ad Elsevier MCF-7 Elsevier Ir Elsevier CvME Elsevier CPPs Elsevier HeLa Elsevier DQA Elsevier LSDs Elsevier TPP Elsevier NCs Elsevier B55 Elsevier Phis Elsevier HIV Elsevier ICP Elsevier NER Elsevier ATP Elsevier CPT Elsevier TAT Elsevier HNPs Elsevier LRP Elsevier VNB Elsevier ELS Elsevier MTS Elsevier IUSs Elsevier Tf Elsevier MD Elsevier mTOR Elsevier SNPs Elsevier Gb3 Elsevier IDS Elsevier MDR Elsevier NLSs Elsevier PSD Elsevier P-gp Elsevier VAMP Elsevier IMM Elsevier N9 Elsevier MAPK Elsevier ER Elsevier IMS Elsevier RGD Elsevier ERHNPs Elsevier LCVs Elsevier NE Elsevier ROS Elsevier PCL Elsevier ANG Elsevier HPMA Elsevier QDs Elsevier NP Elsevier LIMP Elsevier PLA Elsevier GILT Elsevier EGFP Elsevier FR Elsevier MSNP Elsevier STxB Elsevier EGFR Elsevier PLL Elsevier AuNPs Elsevier HepG2 Elsevier GA Elsevier GSH Elsevier DOPE Elsevier ApDCs Elsevier GI Elsevier EGF Elsevier Fab Elsevier M6P Elsevier FPs Elsevier RAW 264.7 Elsevier SNAP Elsevier GALA Elsevier LMP Elsevier PEG Elsevier PLGA Elsevier PEI Elsevier NPCs Elsevier DOTAP Elsevier LAMP Elsevier DMMA Elsevier |
topic |
ddc 610 ssgn 15,3 fid PHARM bkl 44.40 Elsevier TfR Elsevier BBB Elsevier PS Elsevier EPR Elsevier MHC Elsevier HT Elsevier OLL Elsevier GLS Elsevier Nups Elsevier PI3K Elsevier UPR Elsevier IA Elsevier CME Elsevier NDDSs Elsevier R8 Elsevier DOX Elsevier OMM Elsevier PAMAM Elsevier AR Elsevier DLCs Elsevier SV40 Elsevier LCST Elsevier Ab Elsevier ABC Elsevier Ad Elsevier MCF-7 Elsevier Ir Elsevier CvME Elsevier CPPs Elsevier HeLa Elsevier DQA Elsevier LSDs Elsevier TPP Elsevier NCs Elsevier B55 Elsevier Phis Elsevier HIV Elsevier ICP Elsevier NER Elsevier ATP Elsevier CPT Elsevier TAT Elsevier HNPs Elsevier LRP Elsevier VNB Elsevier ELS Elsevier MTS Elsevier IUSs Elsevier Tf Elsevier MD Elsevier mTOR Elsevier SNPs Elsevier Gb3 Elsevier IDS Elsevier MDR Elsevier NLSs Elsevier PSD Elsevier P-gp Elsevier VAMP Elsevier IMM Elsevier N9 Elsevier MAPK Elsevier ER Elsevier IMS Elsevier RGD Elsevier ERHNPs Elsevier LCVs Elsevier NE Elsevier ROS Elsevier PCL Elsevier ANG Elsevier HPMA Elsevier QDs Elsevier NP Elsevier LIMP Elsevier PLA Elsevier GILT Elsevier EGFP Elsevier FR Elsevier MSNP Elsevier STxB Elsevier EGFR Elsevier PLL Elsevier AuNPs Elsevier HepG2 Elsevier GA Elsevier GSH Elsevier DOPE Elsevier ApDCs Elsevier GI Elsevier EGF Elsevier Fab Elsevier M6P Elsevier FPs Elsevier RAW 264.7 Elsevier SNAP Elsevier GALA Elsevier LMP Elsevier PEG Elsevier PLGA Elsevier PEI Elsevier NPCs Elsevier DOTAP Elsevier LAMP Elsevier DMMA |
topic_unstemmed |
ddc 610 ssgn 15,3 fid PHARM bkl 44.40 Elsevier TfR Elsevier BBB Elsevier PS Elsevier EPR Elsevier MHC Elsevier HT Elsevier OLL Elsevier GLS Elsevier Nups Elsevier PI3K Elsevier UPR Elsevier IA Elsevier CME Elsevier NDDSs Elsevier R8 Elsevier DOX Elsevier OMM Elsevier PAMAM Elsevier AR Elsevier DLCs Elsevier SV40 Elsevier LCST Elsevier Ab Elsevier ABC Elsevier Ad Elsevier MCF-7 Elsevier Ir Elsevier CvME Elsevier CPPs Elsevier HeLa Elsevier DQA Elsevier LSDs Elsevier TPP Elsevier NCs Elsevier B55 Elsevier Phis Elsevier HIV Elsevier ICP Elsevier NER Elsevier ATP Elsevier CPT Elsevier TAT Elsevier HNPs Elsevier LRP Elsevier VNB Elsevier ELS Elsevier MTS Elsevier IUSs Elsevier Tf Elsevier MD Elsevier mTOR Elsevier SNPs Elsevier Gb3 Elsevier IDS Elsevier MDR Elsevier NLSs Elsevier PSD Elsevier P-gp Elsevier VAMP Elsevier IMM Elsevier N9 Elsevier MAPK Elsevier ER Elsevier IMS Elsevier RGD Elsevier ERHNPs Elsevier LCVs Elsevier NE Elsevier ROS Elsevier PCL Elsevier ANG Elsevier HPMA Elsevier QDs Elsevier NP Elsevier LIMP Elsevier PLA Elsevier GILT Elsevier EGFP Elsevier FR Elsevier MSNP Elsevier STxB Elsevier EGFR Elsevier PLL Elsevier AuNPs Elsevier HepG2 Elsevier GA Elsevier GSH Elsevier DOPE Elsevier ApDCs Elsevier GI Elsevier EGF Elsevier Fab Elsevier M6P Elsevier FPs Elsevier RAW 264.7 Elsevier SNAP Elsevier GALA Elsevier LMP Elsevier PEG Elsevier PLGA Elsevier PEI Elsevier NPCs Elsevier DOTAP Elsevier LAMP Elsevier DMMA |
topic_browse |
ddc 610 ssgn 15,3 fid PHARM bkl 44.40 Elsevier TfR Elsevier BBB Elsevier PS Elsevier EPR Elsevier MHC Elsevier HT Elsevier OLL Elsevier GLS Elsevier Nups Elsevier PI3K Elsevier UPR Elsevier IA Elsevier CME Elsevier NDDSs Elsevier R8 Elsevier DOX Elsevier OMM Elsevier PAMAM Elsevier AR Elsevier DLCs Elsevier SV40 Elsevier LCST Elsevier Ab Elsevier ABC Elsevier Ad Elsevier MCF-7 Elsevier Ir Elsevier CvME Elsevier CPPs Elsevier HeLa Elsevier DQA Elsevier LSDs Elsevier TPP Elsevier NCs Elsevier B55 Elsevier Phis Elsevier HIV Elsevier ICP Elsevier NER Elsevier ATP Elsevier CPT Elsevier TAT Elsevier HNPs Elsevier LRP Elsevier VNB Elsevier ELS Elsevier MTS Elsevier IUSs Elsevier Tf Elsevier MD Elsevier mTOR Elsevier SNPs Elsevier Gb3 Elsevier IDS Elsevier MDR Elsevier NLSs Elsevier PSD Elsevier P-gp Elsevier VAMP Elsevier IMM Elsevier N9 Elsevier MAPK Elsevier ER Elsevier IMS Elsevier RGD Elsevier ERHNPs Elsevier LCVs Elsevier NE Elsevier ROS Elsevier PCL Elsevier ANG Elsevier HPMA Elsevier QDs Elsevier NP Elsevier LIMP Elsevier PLA Elsevier GILT Elsevier EGFP Elsevier FR Elsevier MSNP Elsevier STxB Elsevier EGFR Elsevier PLL Elsevier AuNPs Elsevier HepG2 Elsevier GA Elsevier GSH Elsevier DOPE Elsevier ApDCs Elsevier GI Elsevier EGF Elsevier Fab Elsevier M6P Elsevier FPs Elsevier RAW 264.7 Elsevier SNAP Elsevier GALA Elsevier LMP Elsevier PEG Elsevier PLGA Elsevier PEI Elsevier NPCs Elsevier DOTAP Elsevier LAMP Elsevier DMMA |
format_facet |
Elektronische Aufsätze Aufsätze Elektronische Ressource |
format_main_str_mv |
Text Zeitschrift/Artikel |
carriertype_str_mv |
zu |
author2_variant |
x w xw z c zc x z xz g y gy s z sz |
hierarchy_parent_title |
Assessing the potential of solid dispersions to improve dissolution rate and bioavailability of valsartan: |
hierarchy_parent_id |
ELV000698369 |
dewey-tens |
610 - Medicine & health |
hierarchy_top_title |
Assessing the potential of solid dispersions to improve dissolution rate and bioavailability of valsartan: |
isfreeaccess_txt |
false |
familylinks_str_mv |
(DE-627)ELV000698369 |
title |
Multifunctional nanoplatforms for subcellular delivery of drugs in cancer therapy |
ctrlnum |
(DE-627)ELV048151564 (ELSEVIER)S0079-6425(19)30081-7 |
title_full |
Multifunctional nanoplatforms for subcellular delivery of drugs in cancer therapy |
author_sort |
Guo, Xing |
journal |
Assessing the potential of solid dispersions to improve dissolution rate and bioavailability of valsartan: |
journalStr |
Assessing the potential of solid dispersions to improve dissolution rate and bioavailability of valsartan: |
lang_code |
eng |
isOA_bool |
false |
dewey-hundreds |
600 - Technology |
recordtype |
marc |
publishDateSort |
2020 |
contenttype_str_mv |
zzz |
container_start_page |
0 |
author_browse |
Guo, Xing |
container_volume |
107 |
class |
610 VZ 15,3 ssgn PHARM DE-84 fid 44.40 bkl |
format_se |
Elektronische Aufsätze |
author-letter |
Guo, Xing |
doi_str_mv |
10.1016/j.pmatsci.2019.100599 |
dewey-full |
610 |
title_sort |
multifunctional nanoplatforms for subcellular delivery of drugs in cancer therapy |
title_auth |
Multifunctional nanoplatforms for subcellular delivery of drugs in cancer therapy |
abstract |
To achieve highly effective treatment to diseases, successful delivery of drugs with a carrier into the specific organelles (nucleus, mitochondria, lysosomes, etc.) is of great importance. Targeted delivery based on nanoparticle (NP)-based drug delivery systems (NDDSs) is mainly focused on cell-membrane targeting. In this review we summarize researches on organelle-specific drug delivery with multifunctional NPs. Many effective strategies are introduced for functionalizing these NPs by altering their chemical composition or by grafting functional groups onto their surface for improving organelle-targeting ability. Only when the concentrationof released drugs becomes high enough will they interact with molecular targets on specific organelles to induce tumor cell apoptosis. Organelle-specific delivery will become one of the primary goals for targeted drug delivery research. |
abstractGer |
To achieve highly effective treatment to diseases, successful delivery of drugs with a carrier into the specific organelles (nucleus, mitochondria, lysosomes, etc.) is of great importance. Targeted delivery based on nanoparticle (NP)-based drug delivery systems (NDDSs) is mainly focused on cell-membrane targeting. In this review we summarize researches on organelle-specific drug delivery with multifunctional NPs. Many effective strategies are introduced for functionalizing these NPs by altering their chemical composition or by grafting functional groups onto their surface for improving organelle-targeting ability. Only when the concentrationof released drugs becomes high enough will they interact with molecular targets on specific organelles to induce tumor cell apoptosis. Organelle-specific delivery will become one of the primary goals for targeted drug delivery research. |
abstract_unstemmed |
To achieve highly effective treatment to diseases, successful delivery of drugs with a carrier into the specific organelles (nucleus, mitochondria, lysosomes, etc.) is of great importance. Targeted delivery based on nanoparticle (NP)-based drug delivery systems (NDDSs) is mainly focused on cell-membrane targeting. In this review we summarize researches on organelle-specific drug delivery with multifunctional NPs. Many effective strategies are introduced for functionalizing these NPs by altering their chemical composition or by grafting functional groups onto their surface for improving organelle-targeting ability. Only when the concentrationof released drugs becomes high enough will they interact with molecular targets on specific organelles to induce tumor cell apoptosis. Organelle-specific delivery will become one of the primary goals for targeted drug delivery research. |
collection_details |
GBV_USEFLAG_U GBV_ELV SYSFLAG_U FID-PHARM SSG-OLC-PHA SSG-OPC-PHA |
title_short |
Multifunctional nanoplatforms for subcellular delivery of drugs in cancer therapy |
url |
https://doi.org/10.1016/j.pmatsci.2019.100599 |
remote_bool |
true |
author2 |
Wei, Xiao Chen, Zi Zhang, Xiaobin Yang, Guang Zhou, Shaobing |
author2Str |
Wei, Xiao Chen, Zi Zhang, Xiaobin Yang, Guang Zhou, Shaobing |
ppnlink |
ELV000698369 |
mediatype_str_mv |
z |
isOA_txt |
false |
hochschulschrift_bool |
false |
author2_role |
oth oth oth oth oth |
doi_str |
10.1016/j.pmatsci.2019.100599 |
up_date |
2024-07-06T18:04:31.098Z |
_version_ |
1803853833018802176 |
fullrecord_marcxml |
<?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>01000caa a22002652 4500</leader><controlfield tag="001">ELV048151564</controlfield><controlfield tag="003">DE-627</controlfield><controlfield tag="005">20230626021305.0</controlfield><controlfield tag="007">cr uuu---uuuuu</controlfield><controlfield tag="008">191023s2020 xx |||||o 00| ||eng c</controlfield><datafield tag="024" ind1="7" ind2=" "><subfield code="a">10.1016/j.pmatsci.2019.100599</subfield><subfield code="2">doi</subfield></datafield><datafield tag="028" ind1="5" ind2="2"><subfield code="a">GBV00000000000776.pica</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-627)ELV048151564</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(ELSEVIER)S0079-6425(19)30081-7</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-627</subfield><subfield code="b">ger</subfield><subfield code="c">DE-627</subfield><subfield code="e">rakwb</subfield></datafield><datafield tag="041" ind1=" " ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="082" ind1="0" ind2="4"><subfield code="a">610</subfield><subfield code="q">VZ</subfield></datafield><datafield tag="084" ind1=" " ind2=" "><subfield code="a">15,3</subfield><subfield code="2">ssgn</subfield></datafield><datafield tag="084" ind1=" " ind2=" "><subfield code="a">PHARM</subfield><subfield code="q">DE-84</subfield><subfield code="2">fid</subfield></datafield><datafield tag="084" ind1=" " ind2=" "><subfield code="a">44.40</subfield><subfield code="2">bkl</subfield></datafield><datafield tag="100" ind1="1" ind2=" "><subfield code="a">Guo, Xing</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Multifunctional nanoplatforms for subcellular delivery of drugs in cancer therapy</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="c">2020transfer abstract</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">zzz</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">z</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">zu</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="520" ind1=" " ind2=" "><subfield code="a">To achieve highly effective treatment to diseases, successful delivery of drugs with a carrier into the specific organelles (nucleus, mitochondria, lysosomes, etc.) is of great importance. Targeted delivery based on nanoparticle (NP)-based drug delivery systems (NDDSs) is mainly focused on cell-membrane targeting. In this review we summarize researches on organelle-specific drug delivery with multifunctional NPs. Many effective strategies are introduced for functionalizing these NPs by altering their chemical composition or by grafting functional groups onto their surface for improving organelle-targeting ability. Only when the concentrationof released drugs becomes high enough will they interact with molecular targets on specific organelles to induce tumor cell apoptosis. Organelle-specific delivery will become one of the primary goals for targeted drug delivery research.</subfield></datafield><datafield tag="520" ind1=" " ind2=" "><subfield code="a">To achieve highly effective treatment to diseases, successful delivery of drugs with a carrier into the specific organelles (nucleus, mitochondria, lysosomes, etc.) is of great importance. Targeted delivery based on nanoparticle (NP)-based drug delivery systems (NDDSs) is mainly focused on cell-membrane targeting. In this review we summarize researches on organelle-specific drug delivery with multifunctional NPs. Many effective strategies are introduced for functionalizing these NPs by altering their chemical composition or by grafting functional groups onto their surface for improving organelle-targeting ability. Only when the concentrationof released drugs becomes high enough will they interact with molecular targets on specific organelles to induce tumor cell apoptosis. Organelle-specific delivery will become one of the primary goals for targeted drug delivery research.</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">TfR</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">BBB</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">PS</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">EPR</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">MHC</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">HT</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">OLL</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">GLS</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Nups</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">PI3K</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">UPR</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">IA</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">CME</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">NDDSs</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">R8</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">DOX</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">OMM</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">PAMAM</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">AR</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">DLCs</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">SV40</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">LCST</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Ab</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">ABC</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Ad</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">MCF-7</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Ir</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">CvME</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">CPPs</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">HeLa</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">DQA</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">LSDs</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">TPP</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">NCs</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">B55</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Phis</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">HIV</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">ICP</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">NER</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">ATP</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">CPT</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">TAT</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">HNPs</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">LRP</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">VNB</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">ELS</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">MTS</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">IUSs</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Tf</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">MD</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">mTOR</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">SNPs</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Gb3</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">IDS</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">MDR</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">NLSs</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">PSD</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">P-gp</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">VAMP</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">IMM</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">N9</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">MAPK</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">ER</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">IMS</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">RGD</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">ERHNPs</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">LCVs</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">NE</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">ROS</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">PCL</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">ANG</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">HPMA</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">QDs</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">NP</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">LIMP</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">PLA</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">GILT</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">EGFP</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">FR</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">MSNP</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">STxB</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">EGFR</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">PLL</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">AuNPs</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">HepG2</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">GA</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">GSH</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">DOPE</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">ApDCs</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">GI</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">EGF</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Fab</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">M6P</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">FPs</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">RAW 264.7</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">SNAP</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">GALA</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">LMP</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">PEG</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">PLGA</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">PEI</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">NPCs</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">DOTAP</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">LAMP</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">DMMA</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Wei, Xiao</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Chen, Zi</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Zhang, Xiaobin</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Yang, Guang</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Zhou, Shaobing</subfield><subfield code="4">oth</subfield></datafield><datafield tag="773" ind1="0" ind2="8"><subfield code="i">Enthalten in</subfield><subfield code="n">Elsevier Science</subfield><subfield code="a">Medarević, Djordje ELSEVIER</subfield><subfield code="t">Assessing the potential of solid dispersions to improve dissolution rate and bioavailability of valsartan:</subfield><subfield code="d">2018</subfield><subfield code="g">Amsterdam [u.a.]</subfield><subfield code="w">(DE-627)ELV000698369</subfield></datafield><datafield tag="773" ind1="1" ind2="8"><subfield code="g">volume:107</subfield><subfield code="g">year:2020</subfield><subfield code="g">pages:0</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">https://doi.org/10.1016/j.pmatsci.2019.100599</subfield><subfield code="3">Volltext</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_USEFLAG_U</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ELV</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SYSFLAG_U</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">FID-PHARM</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SSG-OLC-PHA</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SSG-OPC-PHA</subfield></datafield><datafield tag="936" ind1="b" ind2="k"><subfield code="a">44.40</subfield><subfield code="j">Pharmazie</subfield><subfield code="j">Pharmazeutika</subfield><subfield code="q">VZ</subfield></datafield><datafield tag="951" ind1=" " ind2=" "><subfield code="a">AR</subfield></datafield><datafield tag="952" ind1=" " ind2=" "><subfield code="d">107</subfield><subfield code="j">2020</subfield><subfield code="h">0</subfield></datafield></record></collection>
|
score |
7.4016542 |